|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02269 WUXI BIO
Nominal 
16.760 +0.440 (+2.696%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 4,667,712 | 5,541,673 | 3,431,258 | 1,881,276 |
| Net Cash from / (used in) Investing Activities | -- | (3,228,266) | (5,908,252) | (9,601,670) | (7,216,283) |
| Net Cash from / (used in) Financing Activities | -- | 1,961,163 | (2,591,592) | 8,209,459 | 6,565,644 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 3,400,609 | (2,958,171) | 2,039,047 | 1,230,637 |
| Cash & Cash Equivalents at beginning of period | -- | 6,395,222 | 9,003,280 | 7,095,735 | 6,205,496 |
| Effect of Foreign Exchange Rate Changes | -- | (125,992) | 350,113 | (131,502) | (340,398) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 9,669,839 | 6,395,222 | 9,003,280 | 7,095,735 |
| Remarks: | Real time quote last updated: 04/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,499,080 |
| %Change | -33.864% |
| EPS / (LPS) | RMB 0.370 |
| NBV Per Share (¥) | RMB 9.789 |